AAPL345.16+1.17 (+0.34%) ▲|ABBV283.70-1.11 (-0.39%) ▼|ABT102.40+1.89 (+1.88%) ▲|ACN250.63+10.37 (+4.32%) ▲|ADBE270.41+15.35 (+6.02%) ▲|AMAT382.87-26.07 (-6.38%) ▼|AMD515.87-36.85 (-6.67%) ▼|AMGN448.50+10.16 (+2.32%) ▲|AMT181.12+3.48 (+1.96%) ▲|AMZN252.83-9.54 (-3.64%) ▼|AVGO325.60-12.21 (-3.61%) ▼|AXP323.72+0.11 (+0.03%) ▲|BA189.87-2.41 (-1.25%) ▼|BAC50.94+0.16 (+0.31%) ▲|BKNG162.10+3.72 (+2.35%) ▲|BLK1,141.03-8.57 (-0.75%) ▼|BMY62.79+1.67 (+2.73%) ▲|BNY144.18-1.67 (-1.15%) ▼|BRK-B548.48+9.49 (+1.76%) ▲|C122.15-1.71 (-1.38%) ▼|CAT705.10-35.12 (-4.74%) ▼|CL96.83+3.43 (+3.67%) ▲|CMCSA22.88+0.80 (+3.62%) ▲|COF204.44-2.23 (-1.08%) ▼|COP144.88-0.79 (-0.54%) ▼|COST1,009.82+11.51 (+1.15%) ▲|CRM249.25+7.47 (+3.09%) ▲|CSCO104.56-2.71 (-2.52%) ▼|CVS93.99+1.21 (+1.30%) ▲|CVX224.37-2.41 (-1.06%) ▼|DE638.30+1.76 (+0.28%) ▲|DHR232.42-1.45 (-0.62%) ▼|DIS113.00+1.17 (+1.05%) ▲|DUK123.57+2.90 (+2.40%) ▲|EMR158.15-4.96 (-3.04%) ▼|FDX301.75+3.52 (+1.18%) ▲|GD346.66+1.95 (+0.57%) ▲|GE291.48-4.40 (-1.49%) ▼|GEV829.29-96.63 (-10.44%) ▼|GILD155.79+2.22 (+1.45%) ▲|GM76.95+0.84 (+1.10%) ▲|GOOG323.64-7.31 (-2.21%) ▼|GOOGL327.55-7.21 (-2.15%) ▼|GS891.71-13.01 (-1.44%) ▼|HD324.76+10.62 (+3.38%) ▲|HON215.50+0.77 (+0.36%) ▲|IBM249.07-2.40 (-0.95%) ▼|INTC87.75-5.21 (-5.60%) ▼|INTU355.65+20.04 (+5.97%) ▲|ISRG439.80+11.68 (+2.73%) ▲|JNJ266.77+8.99 (+3.49%) ▲|JPM334.54-0.65 (-0.19%) ▼|KO94.65+1.97 (+2.13%) ▲|LIN509.18+8.61 (+1.72%) ▲|LLY1,313.27+42.52 (+3.35%) ▲|LMT582.25+30.74 (+5.57%) ▲|LOW203.69+7.13 (+3.62%) ▲|LRCX235.46-25.35 (-9.72%) ▼|MA631.93+9.31 (+1.49%) ▲|MCD250.60+4.35 (+1.77%) ▲|MDLZ64.33+1.59 (+2.53%) ▲|MDT95.78+2.75 (+2.96%) ▲|META654.00-43.52 (-6.24%) ▼|MMM174.01-0.73 (-0.42%) ▼|MO75.39+1.56 (+2.11%) ▲|MRK152.09+2.21 (+1.47%) ▲|MS183.81-3.20 (-1.71%) ▼|MSFT526.09-6.86 (-1.29%) ▼|MU870.16-43.52 (-4.76%) ▼|NEE80.74+2.46 (+3.14%) ▲|NFLX67.23+2.19 (+3.36%) ▲|NKE38.25+0.72 (+1.92%) ▲|NOW156.61+3.49 (+2.28%) ▲|NVDA213.86-8.12 (-3.66%) ▼|ORCL126.23-2.90 (-2.25%) ▼|PEP137.97+3.27 (+2.43%) ▲|PFE30.27+0.42 (+1.39%) ▲|PG166.03+9.19 (+5.86%) ▲|PLTR199.03-2.69 (-1.33%) ▼|PM200.96+3.50 (+1.77%) ▲|QCOM175.40-2.57 (-1.44%) ▼|RTX191.82+0.22 (+0.11%) ▲|SBUX101.53+2.45 (+2.47%) ▲|SCHW92.34+0.70 (+0.76%) ▲|SO92.79+2.40 (+2.66%) ▲|SPG210.17+4.62 (+2.25%) ▲|T22.53+0.62 (+2.81%) ▲|TMO683.47-10.55 (-1.52%) ▼|TMUS157.52+3.77 (+2.45%) ▲|TSLA381.59-4.89 (-1.26%) ▼|TXN282.10-2.56 (-0.90%) ▼|UBER68.58+0.96 (+1.41%) ▲|UNH425.88+8.88 (+2.13%) ▲|UNP295.77+7.90 (+2.74%) ▲|UPS101.25+1.68 (+1.69%) ▲|USB59.89+0.84 (+1.41%) ▲|V414.18+6.33 (+1.55%) ▲|VZ44.59+1.03 (+2.36%) ▲|WFC83.08+0.66 (+0.80%) ▲|WMT120.13+2.33 (+1.98%) ▲|XOM176.13-1.97 (-1.10%) ▼|AAPL345.16+1.17 (+0.34%) ▲|ABBV283.70-1.11 (-0.39%) ▼|ABT102.40+1.89 (+1.88%) ▲|ACN250.63+10.37 (+4.32%) ▲|ADBE270.41+15.35 (+6.02%) ▲|AMAT382.87-26.07 (-6.38%) ▼|AMD515.87-36.85 (-6.67%) ▼|AMGN448.50+10.16 (+2.32%) ▲|AMT181.12+3.48 (+1.96%) ▲|AMZN252.83-9.54 (-3.64%) ▼|AVGO325.60-12.21 (-3.61%) ▼|AXP323.72+0.11 (+0.03%) ▲|BA189.87-2.41 (-1.25%) ▼|BAC50.94+0.16 (+0.31%) ▲|BKNG162.10+3.72 (+2.35%) ▲|BLK1,141.03-8.57 (-0.75%) ▼|BMY62.79+1.67 (+2.73%) ▲|BNY144.18-1.67 (-1.15%) ▼|BRK-B548.48+9.49 (+1.76%) ▲|C122.15-1.71 (-1.38%) ▼|CAT705.10-35.12 (-4.74%) ▼|CL96.83+3.43 (+3.67%) ▲|CMCSA22.88+0.80 (+3.62%) ▲|COF204.44-2.23 (-1.08%) ▼|COP144.88-0.79 (-0.54%) ▼|COST1,009.82+11.51 (+1.15%) ▲|CRM249.25+7.47 (+3.09%) ▲|CSCO104.56-2.71 (-2.52%) ▼|CVS93.99+1.21 (+1.30%) ▲|CVX224.37-2.41 (-1.06%) ▼|DE638.30+1.76 (+0.28%) ▲|DHR232.42-1.45 (-0.62%) ▼|DIS113.00+1.17 (+1.05%) ▲|DUK123.57+2.90 (+2.40%) ▲|EMR158.15-4.96 (-3.04%) ▼|FDX301.75+3.52 (+1.18%) ▲|GD346.66+1.95 (+0.57%) ▲|GE291.48-4.40 (-1.49%) ▼|GEV829.29-96.63 (-10.44%) ▼|GILD155.79+2.22 (+1.45%) ▲|GM76.95+0.84 (+1.10%) ▲|GOOG323.64-7.31 (-2.21%) ▼|GOOGL327.55-7.21 (-2.15%) ▼|GS891.71-13.01 (-1.44%) ▼|HD324.76+10.62 (+3.38%) ▲|HON215.50+0.77 (+0.36%) ▲|IBM249.07-2.40 (-0.95%) ▼|INTC87.75-5.21 (-5.60%) ▼|INTU355.65+20.04 (+5.97%) ▲|ISRG439.80+11.68 (+2.73%) ▲|JNJ266.77+8.99 (+3.49%) ▲|JPM334.54-0.65 (-0.19%) ▼|KO94.65+1.97 (+2.13%) ▲|LIN509.18+8.61 (+1.72%) ▲|LLY1,313.27+42.52 (+3.35%) ▲|LMT582.25+30.74 (+5.57%) ▲|LOW203.69+7.13 (+3.62%) ▲|LRCX235.46-25.35 (-9.72%) ▼|MA631.93+9.31 (+1.49%) ▲|MCD250.60+4.35 (+1.77%) ▲|MDLZ64.33+1.59 (+2.53%) ▲|MDT95.78+2.75 (+2.96%) ▲|META654.00-43.52 (-6.24%) ▼|MMM174.01-0.73 (-0.42%) ▼|MO75.39+1.56 (+2.11%) ▲|MRK152.09+2.21 (+1.47%) ▲|MS183.81-3.20 (-1.71%) ▼|MSFT526.09-6.86 (-1.29%) ▼|MU870.16-43.52 (-4.76%) ▼|NEE80.74+2.46 (+3.14%) ▲|NFLX67.23+2.19 (+3.36%) ▲|NKE38.25+0.72 (+1.92%) ▲|NOW156.61+3.49 (+2.28%) ▲|NVDA213.86-8.12 (-3.66%) ▼|ORCL126.23-2.90 (-2.25%) ▼|PEP137.97+3.27 (+2.43%) ▲|PFE30.27+0.42 (+1.39%) ▲|PG166.03+9.19 (+5.86%) ▲|PLTR199.03-2.69 (-1.33%) ▼|PM200.96+3.50 (+1.77%) ▲|QCOM175.40-2.57 (-1.44%) ▼|RTX191.82+0.22 (+0.11%) ▲|SBUX101.53+2.45 (+2.47%) ▲|SCHW92.34+0.70 (+0.76%) ▲|SO92.79+2.40 (+2.66%) ▲|SPG210.17+4.62 (+2.25%) ▲|T22.53+0.62 (+2.81%) ▲|TMO683.47-10.55 (-1.52%) ▼|TMUS157.52+3.77 (+2.45%) ▲|TSLA381.59-4.89 (-1.26%) ▼|TXN282.10-2.56 (-0.90%) ▼|UBER68.58+0.96 (+1.41%) ▲|UNH425.88+8.88 (+2.13%) ▲|UNP295.77+7.90 (+2.74%) ▲|UPS101.25+1.68 (+1.69%) ▲|USB59.89+0.84 (+1.41%) ▲|V414.18+6.33 (+1.55%) ▲|VZ44.59+1.03 (+2.36%) ▲|WFC83.08+0.66 (+0.80%) ▲|WMT120.13+2.33 (+1.98%) ▲|XOM176.13-1.97 (-1.10%) ▼|
16.1 C
New York
Thursday, October 22, 2026

Tag: diseases

newsFORsourcecompanycontentinformation1releasesmarket

THR-β Agonist Market on the Rise: Insights and Projections Upto 2034 | DelveInsight

The THR‑β agonist market is witnessing rapid growth, fueled by the increasing global prevalence of metabolic disorders such as MASH and rare genetic conditions...

THR-β Agonist Market on the Rise: Insights and Projections Upto 2034 | DelveInsight

The THR‑β agonist market is witnessing rapid growth, fueled by the increasing global prevalence of metabolic disorders such as MASH and rare genetic conditions...

Pilgrim’s Pride Reports Second Quarter 2025 Results with $4.8 Billion in Net Sales, Operating Income of $512.3 Million and Announces Special Dividend of Approximately...

GREELEY, Colo., July 30, 2025 (GLOBE NEWSWIRE) -- Pilgrim’s Pride Corporation (NASDAQ: PPC), one of the world's leading food companies, reports its second quarter 2025 financial results.

Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, August 6, 2025, to report its second quarter 2025 financial results and provide a corporate update.

AGNICO EAGLE REPORTS SECOND QUARTER 2025 RESULTS – RECORD FREE CASH FLOW WITH ANOTHER QUARTER OF STRONG PRODUCTION AND COST PERFORMANCE; BALANCE SHEET FURTHER...

Stock Symbol: AEM (NYSE and TSX) (All amounts expressed in U.S. dollars unless otherwise noted) TORONTO, July 30, 2025 /CNW/ - Agnico Eagle Mines Limited (NYSE:...

AGNICO EAGLE REPORTS SECOND QUARTER 2025 RESULTS – RECORD FREE CASH FLOW WITH ANOTHER QUARTER OF STRONG PRODUCTION AND COST PERFORMANCE; BALANCE SHEET FURTHER...

Stock Symbol: AEM (NYSE and TSX) (All amounts expressed in U.S. dollars unless otherwise noted) TORONTO, July 30, 2025 /PRNewswire/ - Agnico Eagle Mines Limited (NYSE:...

Extra Space Storage Inc. Reports 2025 Second Quarter Results

SALT LAKE CITY, July 30, 2025 /PRNewswire/ -- Extra Space Storage Inc. (NYSE: EXR) (the "Company"), a leading owner and operator of self-storage facilities...

Artivion to Participate in Upcoming Investor Conferences

ATLANTA, July 30, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it...

Eviva Partners Launches New Think Tank, Exposes Attack on Aluminum-Containing Vaccines

NEW YORK, July 30, 2025 /PRNewswire/ -- Eviva Partners, a nonprofit organization dedicated to strengthening public understanding of medical evidence, is proud to announce...

Everads Announces Two Oral Presentations at ASRS 2025, Including Full Clinical Trial Results with Its Novel Suprachoroidal Injector

– Clinical study confirms safety, feasibility, and tolerability of the Everads Injector– – Preclinical data demonstrate the feasibility of in-office, minimally invasive suprachoroidal buckling using...

ARCHIMED Acquires a Majority Stake in Arkstone, Forging a Powerful Partnership to Accelerate Global Healthcare Innovation And Dominate the Emerging AI-Driven Clinical Decision Support...

Arkstone, an innovative biotechnology company democratizing infectious disease expertise and fighting antimicrobial resistance, has been acquired by global healthcare private equity firm ARCHIMED, which...

Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision

WARREN, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the Company’s significant insider ownership of outstanding common stock, as most recently reported on July 10, 2025, on Form 8-K filed with the Securities and Exchange Commission.

Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis

– Nuvisertib (TP-3654), an oral investigational highly selective PIM-1 kinase inhibitor, is being evaluated in patients with relapsed or refractory myelofibrosis (MF) – MARLBOROUGH, Mass.,...

Information on the total number of voting rights and shares

Press Release - Regulated Information 
Press Release - Regulated Information

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDiseases

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers